Stay updated on Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T14:19:22.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with an access-denied message. This indicates the record is temporarily unavailable.
    Difference
    18%
    Check dated 2026-09-21T20:28:49.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page now shows a new site revision label: v3.6.6, replacing the previous v3.6.5. This reflects a software update and does not modify the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-08-31T17:28:02.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The NIH grant/contract funding line was added to the study's identifiers, indicating U.S. government support for the ADore trial.
    Difference
    0.0%
    Check dated 2026-08-24T19:57:29.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, indicating a small backend/software update rather than a substantive change to study details.
    Difference
    0.0%
    Check dated 2026-08-10T12:47:45.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page now shows a new site revision number (v3.6.4) replacing the previous v3.6.3. This reflects a deployment update rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-07-27T06:30:50.000Z thumbnail image

Stay in the know with updates to Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page.